Bio Plus Co., Ltd (KOSDAQ:099430)
South Korea · Delayed Price · Currency is KRW 4,575.00
-120.00 (-2.56%)
Jun 10, 2026, 3:30 PM KST
Bio Plus Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 281,548 | 309,549 | 411,567 | 392,878 | 402,040 | 394,997 | |
Market Cap Growth | -40.52% | -24.79% | 4.76% | -2.28% | 1.78% | - |
Enterprise Value | 336,317 | 355,362 | 417,681 | 335,049 | 352,354 | 335,962 |
Last Close Price | 4575.00 | 5030.00 | 7207.86 | 6727.68 | 6724.69 | 6594.22 |
PE Ratio | 34.28 | 20.64 | 29.08 | 15.36 | 19.02 | 36.83 |
Forward PE | - | 13.71 | 13.71 | 13.10 | 15.11 | - |
PS Ratio | 2.98 | 3.41 | 6.20 | 6.04 | 7.09 | 10.56 |
PB Ratio | 1.41 | 1.59 | 2.70 | 2.85 | 3.50 | 4.91 |
P/TBV Ratio | 1.67 | 1.86 | 3.27 | 3.25 | 3.63 | 5.19 |
P/FCF Ratio | - | - | - | - | 58.87 | - |
P/OCF Ratio | 16.29 | 17.53 | 15.54 | 19.36 | 30.09 | 29.58 |
EV/Sales Ratio | 3.56 | 3.91 | 6.29 | 5.15 | 6.21 | 8.98 |
EV/EBITDA Ratio | 18.89 | 18.65 | 15.51 | 10.98 | 12.82 | 17.21 |
EV/EBIT Ratio | 25.18 | 23.71 | 17.65 | 11.96 | 13.76 | 18.43 |
EV/FCF Ratio | -24.97 | - | - | - | 51.59 | - |
Debt / Equity Ratio | 0.32 | 0.31 | 0.37 | 0.07 | 0.06 | 0.03 |
Debt / EBITDA Ratio | 3.55 | 3.15 | 2.07 | 0.30 | 0.25 | 0.11 |
Debt / FCF Ratio | - | - | - | - | 0.99 | - |
Net Debt / Equity Ratio | 0.17 | 0.17 | 0.09 | -0.40 | -0.63 | -0.48 |
Net Debt / EBITDA Ratio | 1.85 | 1.73 | 0.52 | -1.83 | -2.63 | -1.99 |
Net Debt / FCF Ratio | -2.47 | -1.14 | -0.20 | 69.39 | -10.57 | 19.83 |
Asset Turnover | 0.33 | 0.33 | 0.30 | 0.41 | 0.48 | 0.59 |
Inventory Turnover | 2.26 | 2.37 | 2.69 | 3.10 | 3.44 | 2.92 |
Quick Ratio | 0.59 | 0.52 | 0.57 | 8.05 | 10.11 | 6.59 |
Current Ratio | 0.94 | 0.84 | 0.71 | 8.88 | 11.19 | 7.26 |
Return on Equity (ROE) | 10.64% | 11.51% | 12.06% | 21.68% | 21.19% | 19.57% |
Return on Assets (ROA) | 2.95% | 3.41% | 6.77% | 10.97% | 13.62% | 18.02% |
Return on Invested Capital (ROIC) | 5.91% | 7.60% | 18.87% | 37.53% | 45.70% | 47.26% |
Return on Capital Employed (ROCE) | 6.10% | 7.20% | 15.10% | 17.30% | 18.70% | 22.50% |
Earnings Yield | 4.97% | 4.85% | 3.44% | 6.51% | 5.26% | 2.71% |
FCF Yield | -4.78% | -9.35% | -16.65% | -0.20% | 1.70% | -0.50% |
Dividend Yield | 1.49% | - | - | 1.04% | 1.04% | - |
Payout Ratio | 20.84% | 19.44% | 29.65% | 16.61% | - | - |
Buyback Yield / Dilution | -19.00% | -19.42% | 5.44% | -5.64% | -10.68% | -3.82% |
Total Shareholder Return | -17.36% | -19.42% | 5.44% | -4.60% | -9.64% | -3.82% |